Log in
Enquire now
‌

US Patent 12090261 Method for modulating endothelial glycocalyx structure

Patent 12090261 was granted and assigned to ExThera Medical on September, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
ExThera Medical
ExThera Medical
0
Current Assignee
ExThera Medical
ExThera Medical
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120902610
Patent Inventor Names
Keith R. McCrea0
Lakhmir (Mink) Chawla0
Robert S. Ward0
Date of Patent
September 17, 2024
0
Patent Application Number
175266630
Date Filed
November 15, 2021
0
Patent Citations
‌
US Patent 8758286 Method for removing cytokines from blood with surface immobilized polysaccharides
0
‌
US Patent 9173989 Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
0
‌
US Patent 9408962 Methods for removing cytokines from blood with surface immobilized polysaccharides
0
‌
US Patent 9669150 Device and method for restoration of the condition of blood
0
‌
US Patent 9764077 Method for extracorporeal removal of pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
0
‌
US Patent 10086126 Methods for removing cytokines from blood with surface immobilized polysaccharides
0
‌
US Patent 10188783 Method for extracorporeal removal of pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
0
‌
US Patent 10457974 Methods for diagnosing infectious diseases using adsorption media
0
...
Patent Primary Examiner
‌
Rosanne Kosson
0
CPC Code
‌
A61K 31/727
0
Patent abstract

The present invention provides methods and devices for augmenting impaired glycocalyx barrier function in a subject in need thereof by contacting a sample (e.g., blood) obtained from the subject with a glycocalyx-mimetic adsorption media. The adsorption media includes glycosaminoglycan structures and, optionally, proteoglycan core proteins, which are conducive to enhancing and/or restoring the impaired glycocalyx barrier function in a sample. The contacted sample is subsequently separated from the adsorption media, producing a treated sample that can be infused into the subject. Methods and devices for treating a patient suffering from a disease associated with glycocalyx barrier dysfunction are also provided herein.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 12090261 Method for modulating endothelial glycocalyx structure

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.